The European Medicines Agency (EMA) has accepted the biopharmaceutical’s request to review the Market Authorization Application (MAA) of Epidiolex, or cannibidiol. The medication is used to treat patients who suffer from seizures linked to Lennox-Gastaut syndrome (LGS) and Dravet syndrome.Cannabidiol (CBD) is a non-psychoactive cannabiniod compound found in industrial hemp and cannabis. Medically, CBD has been shown to have great medicinal value. Benefits are but not limited to: Alleviates Anxiety, Strengthen immune system, Therapeutic, All Natural, Anti-Oxidant, Promotes Glucose Tolerance, Helps with pain, and Non-Habit Forming. Our products are 100% legal because the CBD is extracted from industrial hemp. With industrial hemp only the CBD is extracted. There are many benefits of CBD that are continually being discovered.